Healthcare provider profile · identity verified

Alain Vilatte

Family Practice · PEORIA, IL · NPI 1417039736

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	672	194
Amlodipine Besylate	Amlodipine Besylate	421	121
Omeprazole	Omeprazole	400	109
Lisinopril	Lisinopril	377	114
Levothyroxine Sodium	Levothyroxine Sodium	372	89
Metformin Hcl	Metformin Hcl	300	86
Meloxicam	Meloxicam	261	72
Metoprolol Succinate	Metoprolol Succinate	260	77
Simvastatin	Simvastatin	251	69
Tramadol Hcl	Tramadol Hcl	249	56
Tamsulosin Hcl	Tamsulosin Hcl	233	63
Hydrochlorothiazide	Hydrochlorothiazide	231	74
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	229	71
Rosuvastatin Calcium	Rosuvastatin Calcium	220	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	217	44
Gabapentin	Gabapentin	204	60
Alprazolam	Alprazolam	192	28
Pantoprazole Sodium	Pantoprazole Sodium	161	47
Zolpidem Tartrate	Zolpidem Tartrate	144	22
Furosemide	Furosemide	141	47
Losartan Potassium	Losartan Potassium	139	36
Potassium Chloride	Potassium Chloride	136	31
Allopurinol	Allopurinol	132	37
Pravastatin Sodium	Pravastatin Sodium	131	34
Trazodone Hcl	Trazodone Hcl	126	39
Montelukast Sodium	Montelukast Sodium	123	33
Clopidogrel	Clopidogrel Bisulfate	117	34
Warfarin Sodium	Warfarin Sodium	116	19
Pioglitazone Hcl	Pioglitazone Hcl	106	27
Citalopram Hbr	Citalopram Hydrobromide	105	30
Famotidine	Famotidine	105	24
Lorazepam	Lorazepam	103	25
Albuterol Sulfate Hfa	Albuterol Sulfate	99	32
Fluoxetine Hcl	Fluoxetine Hcl	99	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	96	24
Alendronate Sodium	Alendronate Sodium	88	22
Prednisone	Prednisone	88	54
Tizanidine Hcl	Tizanidine Hcl	85	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	25
Sertraline Hcl	Sertraline Hcl	79	29
Metoprolol Tartrate	Metoprolol Tartrate	77	22
Fluticasone Propionate	Fluticasone Propionate	75	32
Duloxetine Hcl	Duloxetine Hcl	73	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	22
Oxybutynin Chloride Er	Oxybutynin Chloride	72	21
Hydralazine Hcl	Hydralazine Hcl	69	14
Glipizide Er	Glipizide	68	21
Bupropion Xl	Bupropion Hcl	66	20
Eliquis	Apixaban	66	15
Pregabalin	Pregabalin	65	14
Triamcinolone Acetonide	Triamcinolone Acetonide	64	37
Amitriptyline Hcl	Amitriptyline Hcl	61	21
Atenolol	Atenolol	61	13
Metformin Hcl Er	Metformin Hcl	58	18
Irbesartan	Irbesartan	57	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	16
Spironolactone	Spironolactone	57	18
Ezetimibe	Ezetimibe	55	14
Chlorthalidone	Chlorthalidone	54	17
Benazepril Hcl	Benazepril Hcl	53	15
Celecoxib	Celecoxib	50	16
Finasteride	Finasteride	49	17
Venlafaxine Hcl Er	Venlafaxine Hcl	49	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	48	14
Glipizide	Glipizide	45	12
Carvedilol	Carvedilol	44	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	11
Buspirone Hcl	Buspirone Hcl	41	16
Hydroxyzine Hcl	Hydroxyzine Hcl	41	14
Fenofibrate	Fenofibrate	40	11
Donepezil Hcl	Donepezil Hcl	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	32
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Paroxetine Hcl	Paroxetine Hcl	37	12
Propranolol Hcl	Propranolol Hcl	35	11
Lovastatin	Lovastatin	34	suppressed
Topiramate	Topiramate	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	11
Xarelto	Rivaroxaban	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	28
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Cefuroxime	Cefuroxime Axetil	31	28
Indapamide	Indapamide	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Azithromycin	Azithromycin	29	26
Diazepam	Diazepam	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	18
Oxcarbazepine	Oxcarbazepine	24	suppressed
Ozempic	Semaglutide	24	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Fenofibrate	Fenofibrate,micronized	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	13
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Amoxicillin	Amoxicillin	20	15
Gemfibrozil	Gemfibrozil	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Baclofen	Baclofen	18	suppressed
Benztropine Mesylate	Benztropine Mesylate	18	suppressed
Clindamycin Hcl	Clindamycin Hcl	18	13
Myrbetriq	Mirabegron	18	suppressed
Nabumetone	Nabumetone	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Estradiol	Estradiol	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Calcitriol	Calcitriol	16	suppressed
Cephalexin	Cephalexin	16	16
Valsartan	Valsartan	16	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Naproxen	Naproxen	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Bupropion Hcl	Bupropion Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Nystatin	Nystatin	14	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Naltrexone Hcl	Naltrexone Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Tacrolimus	Tacrolimus	12	suppressed
Temazepam	Temazepam	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error